Per Holse Mygind

Per Holse Mygind is a highly experienced professional in the field of biotechnology and pharmaceuticals, currently serving as the Director of Immunogenicity & Biomarkers and Director of Bioanalysis at Ascendis Pharma A/S since May 2016. Previously, Per held the position of Senior Scientist at Novo Nordisk from April 2009 to April 2016, where responsibilities included the development and implementation of advanced immunoassays for detecting and characterizing anti-drug antibodies during drug development phases. Earlier in his career, Per worked as a Research Scientist at Novozymes from January 2001 to March 2009, focusing on project management and the discovery and development of antimicrobial and anti-inflammatory peptides for human therapy. Per holds a Doctor of Philosophy (PhD) in Medical Microbiology and Immunology from Aarhus University, earned between 1990 and 2001, and completed education at Skive Gymnasium from 1984 to 1987.